Milliman Supplemental and Specialty Research
Navigating new and dynamic markets
In-depth research reports featuring rich industry data and insight
Subscription service
Choose the insights that matter to your business
Accident Indemnity and Accident Medical Expense
Download report topic indexCritical Illness
2022 Critical Illness Premium Report IndexHospital Indemnity
Download report topic indexWorksite Life
Download report topic indexDental
Short-Term Care
Compliance
Services related to supplemental and specialty research
Insight related to supplemental and specialty research
‘Insure-TECH’ or ‘INSURE-Tech’? Examining the startup journey to a ‘full-stack’ insurance company
The life insurance industry certainly has seen an increase in technologically savvy InsurTech companies joining its ranks.
The workplace has changed, how will the supplemental benefits market change with it?
Learn about five trends and creative approaches heading into 2022 for supplemental health benefits, on this episode of Critical Point.
Ruff stuff: The time for pet insurance is MEOW
Insurers start to target pet insurance due to high growth and the perception that it remains an untapped market.
Innovate to win: Getting strategic with your [voluntary benefits] plans
Three key questions to identify what your strategy—or plan of action—should look like with your voluntary benefits plans
U.S. supplemental insurance market overview
Our report on the supplement market shows the effects of COVID-19: Inforce premium rose only 1.2% to $62 billion in 2020 from 2019, but still a positive sign.
State of the U.S. supplemental insurance market
In 2019, Milliman conducted a variety of research projects to provide insight into the state of the U.S. supplemental insurance market.
Innovate to win: Why market research is key to insurance industry success
How can insurers leverage these breakthroughs to address unmet consumer demand, successfully launch new insurance products, and drive down costs?
Innovate to Win: Harnessing the power of data
Data is a key component when you are attempting to identify opportunities and quantify the impact of innovative ideas.
Innovate to win: Insurance industry roadmap to success
For insurers, innovation is a key factor to increasing market share and improving customer retention.
Innovate to win: Overcoming regulatory barriers to insurance product and service innovation
Because insurance regulation moves slowly and innovation moves fast, a more flexible framework is needed for insurers to rapidly bring innovative products and services to market.
Supplemental health industry for small companies: Challenges and opportunities
Small companies in the supplemental health products market need to understand the unique challenges these products present in order to compete effectively.
Innovation versus governance: Can they coexist?
Changing consumer preferences and technology are driving much of the need for innovation and, as the emergence of COVID-19 has shown, the most vulnerable parts of an industrial sector can be quickly be brought down by an unexpected event.
A look at United States hospital indemnity plans in a COVID-19 environment
This report presents the findings of an analysis focused on isolating and estimating the potential financial impact of COVID-19 on hospital indemnity plans in the United States.
Milli-Byte: Life insurance product management and the COVID-19 pandemic
This survey examines how life insurance carriers are currently reacting to the COVID-19 pandemic.
Milli-Byte follow-up: Life insurance product management and the COVID-19 pandemic
Milliman received responses from 30 carriers for the follow-up Milli-Byte Survey of Life Insurance Product Management and the COVID-19 pandemic.
COVID-19 life and health insurance regulation update
State Departments of Insurance have issued special rules, regulations, and guidance for insurers related to the COVID-19 pandemic. The scope of this report is limited to such information applicable to accident and health insurance only and focuses the impact that COVID-19 regulatory actions have on product administration.